Ads
related to: revlimid- Treatment Option
Find Out More Info About Jaypirca.
Learn About a Treatment Option.
- Learn About Jaypirca
Find Out About Jaypirca.
Read More on the Official Site.
- Taking Jaypirca
Dosing Information.
Side Effects and Safety.
- Support and Resources
Find Out If You Qualify For
Financial Assistance.
- Treatment Option
Search results
Revlimid Generic Competition, Forex Impacts Bristol Myers' Q3 Sales; Reaffirms FY22 Guidance
Benzinga via Yahoo Finance· 2 years agoBristol Myers Squibb & Co (NYSE: BMY) said that its Q3 sales of $11.22 billion fell 3% Y/Y as...
Bristol Myers' Revlimid Takes A 32% Hit As Generics Keep Coming
Investor's Business Daily· 1 year agoBristol Myers Squibb's Revlimid took fewer than expected generic hits in the fourth quarter,...
Bristol Myers' profit beats on better-than-feared Revlimid sales
Reuters via Yahoo Finance· 1 year ago(Reuters) -Bristol Myers Squibb Co on Thursday reported quarterly earnings that beat analysts'...
Bristol-Myers (BMY) Q2 Earnings, Sales Miss, '23 View Lowered
Zacks via Yahoo Finance· 10 months agoBristol-Myers' (BMY) second-quarter 2023 earnings and sales miss estimates due to generic erosion...
Bristol Myers Squibb Proved in Q3 Why Its Diverse Portfolio Makes It a Solid Investment
Motley Fool· 7 months agoBristol Myers Squibb (NYSE: BMY) is one of the largest healthcare companies in the world. The...
Bristol Myers profit beats estimates on resilient Revlimid sales
Reuters via Yahoo Finance· 2 years ago(Reuters) -Bristol Myers Squibb Co on Wednesday reported bigger second-quarter profit than expected...
Bristol Myers (BMY) Loses 10.5% Year-to-Date: What Lies Ahead?
Zacks via Yahoo Finance· 1 year agoBristol-Myers' (BMY) top drugs, Revlimid and Eliquis, face challenges. It remains to be seen if the...
Bristol Myers Skids After Pushing Back A Key $10 Billion Sales Milestone
Investor's Business Daily· 7 months agoBristol Myers Squibb said Thursday it needs another year for its new products to reach $10 billion...
Bristol-Myers (BMY) Q3 Earnings Beat, Sales Decline Y/Y
Zacks via Yahoo Finance· 2 years agoBristol-Myers Squibb Company BMY reported decent results for the third quarter of 2022. The company...
Bristol Myers sales fall, cuts 2023 forecast as drugs face competition
Reuters via AOL· 10 months ago(Reuters) -Bristol Myers Squibb on Thursday said its second-quarter sales fell more than expected...
Ads
related to: revlimid